H.C. Wainwright is acting as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFFP:
- TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
- TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting
- TFF Pharmaceuticals Signals Advancements in Investor Update
- TFF Pharmaceuticals files to sell 147,500 shares of common stock for holders
- TFF Pharmaceuticals announces data from TFF TAC Phase 2 trial